SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer.
CP: Cancer
HIF1 transcription
SF3B1
chromophobe renal cell carcinoma
glycolysis
hypoxia
pancreatic cancer
splicing
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
23 08 2022
23 08 2022
Historique:
received:
26
11
2020
revised:
16
04
2022
accepted:
04
08
2022
entrez:
24
8
2022
pubmed:
25
8
2022
medline:
27
8
2022
Statut:
ppublish
Résumé
Mutations in the splicing factor SF3B1 are frequently occurring in various cancers and drive tumor progression through the activation of cryptic splice sites in multiple genes. Recent studies also demonstrate a positive correlation between the expression levels of wild-type SF3B1 and tumor malignancy. Here, we demonstrate that SF3B1 is a hypoxia-inducible factor (HIF)-1 target gene that positively regulates HIF1 pathway activity. By physically interacting with HIF1α, SF3B1 facilitates binding of the HIF1 complex to hypoxia response elements (HREs) to activate target gene expression. To further validate the relevance of this mechanism for tumor progression, we show that a reduction in SF3B1 levels via monoallelic deletion of Sf3b1 impedes tumor formation and progression via impaired HIF signaling in a mouse model for pancreatic cancer. Our work uncovers an essential role of SF3B1 in HIF1 signaling, thereby providing a potential explanation for the link between high SF3B1 expression and aggressiveness of solid tumors.
Identifiants
pubmed: 36001976
pii: S2211-1247(22)01084-1
doi: 10.1016/j.celrep.2022.111266
pii:
doi:
Substances chimiques
Hypoxia-Inducible Factor 1
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Phosphoproteins
0
RNA Splice Sites
0
RNA Splicing Factors
0
Sf3b1 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
111266Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.